Azzad Asset Management’s Core Laboratories CLB Stock Holding History

Azzad Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,059	Closed	-$265K	–	304
2019 Q4	$265K	Buy	+7,059	New	+$317K	0.03%	344
2018 Q4	–	Sell	-3,224	Closed	-$373K	–	302
2018 Q3	$373K	Buy	3,224 +1,520	+89%	+$171K	0.1%	274
2018 Q2	$215K	Buy	+1,704	New	+$207K	0.06%	298
2014 Q4	–	Sell	-2,616	Closed	-$383K	–	281
2014 Q3	$383K	Buy	2,616 +103	+4%	+$15.9K	0.22%	188
2014 Q2	$420K	Buy	2,513 +19	+0.8%	+$3.38K	0.25%	155
2014 Q1	$495K	Sell	2,494 -257	-9%	-$48.5K	0.33%	127
2013 Q4	$525K	Buy	2,751 +68	+3%	+$12.7K	0.38%	108
2013 Q3	$454K	Hold	2,683	–	–	0.37%	119
2013 Q2	$454K	Buy	+2,683	New	+$380K	0.39%	106

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Azzad Asset Management's CLB Position: Q1 2020 in Review

Azzad Asset Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 7,059 shares — an estimated $265K sold.

Azzad Asset Management first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $525K in Q4 2013. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Azzad Asset Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Azzad Asset Management sold 7,059 Core Laboratories shares in Q1 2020, an estimated $265K.
Azzad Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
Azzad Asset Management's Core Laboratories position peaked at $525K in Q4 2013.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Azzad Asset Management's 13F filing for Q1 2020, filed 1 Apr 2024.